Sector: Life Sciences

Latest content

The Inventing America event showed opposition to the Innovation Act is bi-partisan and getting STRONGer

With competing bills in Congress and lobbying dollars pouring into the fight, it’s fair to say that the patent reform debate is heating up. Earlier this week a coalition of groups including the Association of American Universities, the Association…

05 March 2015

Antitrust is now firmly part of the picture for IP owners in China. Compliance is the next hurdle

Details of the Chinese National Development and Reform Commission’s settlement of its antitrust probe of Qualcomm emerged last week, with the US company slated to pay a $975 million fine and facing significant limitations on its patent licensing…

16 February 2015

LG has as much to gain from its open innovation drive as Korea’s SMEs

LG Group – one of South Korea’s largest chaebol (conglomerates) and parent of companies including LG Electronics, LG Chem and LG Display, among others – announced last week that it would ‘open up’ part of its patent portfolio for use by third…

13 February 2015

After yesterday's pharma IPR attack maybe Erich Spangenberg will next turn his hand to shareholder suits

Those of us who read the predictions for 2015 that Erich Spangenberg made on the IPNav blog on the final day of last year were probably not too surprised to find out yesterday that he has teamed up with activist shareholder and hedge fund owner Kyle…

11 February 2015

India could end up trumping China as a patent dispute venue for many rights holders

China often hogs the limelight when it comes to discussion about which emerging economy will become the next major IP market alongside the United States and Europe. Questions over the Indian authorities’ approach to IP rights have no doubt…

06 February 2015

Pharma company's RMB30 million patent windfall emphasises need for greater Chinese IP value expertise

China’s desperate need for more IP strategy expertise is an issue that this blog has addressed on several occasions previously. A story IAM heard from a senior IP executive at a Chinese pharmaceutical manufacturer last week drives the point home.…

05 February 2015

IP-savvy activist shareholders + declining patent values + tightening patent eligibility = potential trouble for public companies

The PIPCO sector has attracted its share of - sometimes less than sophisticated - investor interest and there are a number of investors that are active around privately-held licensing-based businesses. There are also various kinds of financial model…

26 January 2015

Hammering “trolls” harms US prosperity, says top BASF IP strategist

US legislators have arrived back on Capitol Hill with patent reform again firmly on the agenda. Congressman Bob Goodlatte, chairman of the House of Representatives Judiciary Committee and author of the Innovation Act in the last Congress, has made…

19 January 2015

How patents and licensing underpin the multi-trillion dollar mobile communications economy

A new report has outlined the crucial roles that long-term R&D, a robust IP system and a collaborative approach to technology standards and licensing have played in the development of the mobile sector. The report by the Boston Consulting Group,…

16 January 2015

NPE suits in the US down significantly in 2014 and figures make it clear that SMEs are very much a secondary target

The 2014 Patent Litigation Report published earlier this week by Unified Patents is a treasure trove of statistics. Not surprisingly for a firm whose business model is focused on helping clients defend against “frivolous lawsuits” primarily…

10 January 2015

Unlock unlimited access to all IAM content